These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19817933)

  • 1. What price for blood pressure control?
    Textor SC
    J Clin Hypertens (Greenwich); 2009 Oct; 11(10):537-9. PubMed ID: 19817933
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator.
    Young KC; Teeters JC; Benesch CG; Bisognano JD; Illig KA
    J Clin Hypertens (Greenwich); 2009 Oct; 11(10):555-63. PubMed ID: 19817936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of uncontrollable hypertension with a carotid sinus stimulation device.
    Mohaupt MG; Schmidli J; Luft FC
    Hypertension; 2007 Nov; 50(5):825-8. PubMed ID: 17893424
    [No Abstract]   [Full Text] [Related]  

  • 4. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
    Alnima T; Goedhart EJ; Seelen R; van der Grinten CP; de Leeuw PW; Kroon AA
    Hypertension; 2015 Jun; 65(6):1217-22. PubMed ID: 25941348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. InnovaSEC in Action: Cost-effectiveness of Barostim in the Treatment of Refractory Hypertension in Spain.
    Soto M; Sampietro-Colom L; Sagarra J; Brugada-Terradellas J
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):563-71. PubMed ID: 26907729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [German physicians study new device. Pacemaker for therapy of hypertension? (interview by Dr. Thomas Meissner)].
    Menne J
    MMW Fortschr Med; 2008 Sep; 150(36-37):6. PubMed ID: 18986111
    [No Abstract]   [Full Text] [Related]  

  • 7. Device-based therapies for arterial hypertension.
    Lauder L; Azizi M; Kirtane AJ; Böhm M; Mahfoud F
    Nat Rev Cardiol; 2020 Oct; 17(10):614-628. PubMed ID: 32286512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacral neuromodulation for the treatment of fecal incontinence: analysis of cost-effectiveness.
    Indinnimeo M; Ratto C; Moschella CM; Fiore A; Brosa M; Giardina S
    Dis Colon Rectum; 2010 Dec; 53(12):1661-9. PubMed ID: 21178862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].
    Koziolek M; Beige J; Wallbach M; Zenker D; Henning G; Halbach M; Mader N; Mahfoud F; Schlieper G; Schwenger V; Hausberg M; Börgel J; Lodde M; van der Giet M; Müller-Ehmsen J; Passauer J; Parmentier S; Lüders S; Krämer BK; Büttner S; Limbourg F; Jordan J; Vonend O; Predel HG; Reuter H
    Internist (Berl); 2017 Oct; 58(10):1114-1123. PubMed ID: 28835975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical carotid baroreceptor stimulation.
    Schmidli J; von Allmen RS; Mohaupt MG
    Wien Med Wochenschr; 2014 Dec; 164(23-24):508-14. PubMed ID: 25411011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension.
    Alnima T; Scheffers I; De Leeuw PW; Winkens B; Jongen-Vancraybex H; Tordoir JH; Schmidli J; Mohaupt MG; Allemann Y; Kroon AA
    J Hypertens; 2012 Aug; 30(8):1665-70. PubMed ID: 22728906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical stimulation of the carotid sinus for the treatment of resistant hypertension.
    Filippone JD; Sloand JA; Illig KA; Bisognano JD
    Curr Hypertens Rep; 2006 Oct; 8(5):420-4. PubMed ID: 16965730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathophysiological basis of carotid baroreceptor stimulation for the treatment of resistant hypertension.
    Lovic D; Manolis AJ; Lovic B; Stojanov V; Lovic M; Pittaras A; Jakovljevic B
    Curr Vasc Pharmacol; 2014 Jan; 12(1):16-22. PubMed ID: 23905596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Baroflex stimulation: a novel treatment option for resistant hypertension].
    Eckert S
    MMW Fortschr Med; 2011 Feb; 153(6):49-50. PubMed ID: 21644339
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness analysis of sacral neuromodulation (SNM) with Interstim for fecal incontinence patients in Spain.
    Brosa M; Muñoz-Duyos A; Navarro-Luna A; Rodriguez JM; Serrano D; Gisbert R; Dziekan K; Segú JL
    Curr Med Res Opin; 2008 Mar; 24(3):907-18. PubMed ID: 18279582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.
    Heusser K; Tank J; Engeli S; Diedrich A; Menne J; Eckert S; Peters T; Sweep FC; Haller H; Pichlmaier AM; Luft FC; Jordan J
    Hypertension; 2010 Mar; 55(3):619-26. PubMed ID: 20101001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable device therapy for the treatment of resistant hypertension.
    Joshi N; Taylor J; Bisognano JD
    J Cardiovasc Transl Res; 2009 Jun; 2(2):150-3. PubMed ID: 20559981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings.
    Borisenko O; Beige J; Lovett EG; Hoppe UC; Bjessmo S
    J Hypertens; 2014 Mar; 32(3):681-92. PubMed ID: 24378998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
    Bakris GL; Nadim MK; Haller H; Lovett EG; Schafer JE; Bisognano JD
    J Am Soc Hypertens; 2012; 6(2):152-8. PubMed ID: 22341199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of diaphragm pacing].
    Takeda S; Miyoshi S; Matsuda K; Kido T; Nakahara K
    Masui; 1997 Nov; 46 Suppl():S125-32. PubMed ID: 9508565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.